Better molecules by design

Alberta Biotech Company Receives Canadian Government Funding for Immuno-Oncology Project

August 15, 2018

Edmonton’s General Intermediates of Canada Inc. (GIC) announced today that they have received conditional funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) related to their discovery ...

General Intermediates Successfully Completes Government of Canada Funded Pharmaceutical Project

June 9, 2017

Edmonton’s General Intermediates of Canada Inc. (GIC) announced today that they have successfully completed a research project related to a key starting API material for a global ...

General Intermediates Announces Ability to Produce Bio-Safe, Bio-Molecules for the Pharmaceutical Industry

May 29, 2016

Edmonton’s General Intermediates of Canada Inc. announced today that they have developed a unique process for making specialized bio-molecules for pharmaceutical fermenters, producing them in a certified, bio-safe manner. These ...

General Intermediates Reveals New Cyclization Technique for Production of Pharmaceuticals

May 29, 2016

Edmonton’s General Intermediates of Canada Inc. announced today that they have pioneered a process for simplifying the production of pharmaceuticals. “This proprietary synthesis methodology addresses the age old question faced by any ...

General Intermediates Announces Second Nucleoside Breakthrough

August 8, 2015

General Intermediates Canada announced today that they have the developed a second proprietary technique for nucleoside substitution. This technique applies to all nucleoside synthesis where unique or rare ...